ETV Bharat / Astrazeneca

Astrazeneca

Researchers from Flinders University in Australia and other international experts have found that the British-Swedish pharma giant AstraZeneca's COVID-19 vaccine, made in collaboration with Oxford University raises the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT).

AstraZeneca Covid Vax Linked To Another Rare Fatal Blood Clotting Disorder

2 Min Read

May 16, 2024

IANS

Experts from India’s health domain on Friday said that there is no need to worry about COVID-19 vaccines as most citizens have been administered three doses of the vaccines already.

No Need to Worry About COVID-19 Vaccines in India: Experts

3 Min Read

May 10, 2024

ETV Bharat English Team

Covishield Side Effects: Plea In SC For Vaccine Damage Payment System For Citizens

2 Min Read

May 1, 2024

Sumit Saxena

A landmark case in London's High Court involves Jamie Scott's pursuit against AstraZeneca over a severe brain injury post-Oxford-AstraZeneca vaccination. The dispute highlights using relative risk amidst varying COVID prevalence and the limitations of trial setups on absolute efficacy demonstration. Despite the legal battle, the vaccine's life-saving impact remains undeniable. AstraZeneca prioritizes patient safety while acknowledging reported health issues

AstraZeneca sued over jab: Could it be down to a misunderstanding of how risk is calculated?

Nov 15, 2023

PTI

AstraZeneca Pharma India on Monday said it has received approval for extended indication from the Drugs Controller General of India for Dapagliflozin 10 mg tablets. The company has received permission from the DCGI to import pharmaceutical formulations of a new drug for sale or distribution for Dapagliflozin Tablets 10 mg, the drug firm said in a regulatory filing.

AstraZeneca gets DCGI approval for Dapagliflozin in treatment of heart failure

Jul 24, 2023

AstraZeneca India gets approval to market anti-diabetes drug

Nov 29, 2022

Evidence updated on blood clotting side effect of Covid jab: Study

Oct 27, 2022

AstraZeneca India extends programme on cancer-screening for women in TN

Jun 22, 2022

In an ongoing safety and immunogenicity trial of the Covishield vaccine, it was found that given as a third dose increased the body's immune response to Beta, Delta, Alpha and Gamma SARS-CoV-2 variants.

Third dose of AstraZeneca vaccine effective against Omicron

Jan 13, 2022

AstraZeneca Covid vaccine protection wanes after three months: Lancet study

Dec 21, 2021

USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZeneca

Dec 17, 2021

AstraZeneca in touch with Indian authorities for approval to COVID drug

Dec 9, 2021

Mixing other vaccines with AstraZeneca, Pfizer jabs generates robust immune response: Lancet study

Dec 7, 2021

AstraZeneca's antibody shot 83% effective at preventing Covid

Nov 19, 2021

India can vaccinate all adults by December, say experts

Oct 22, 2021

WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with India

Oct 20, 2021

AstraZeneca's antibody cocktail can prevent, treat Covid-19

Oct 12, 2021

AstraZeneca asks FDA to authorise Covid antibody treatment

Oct 5, 2021

Latest

National Tourism Day Celebrated On January 25 To Highlight Importance Of Tourism For Economic Growth

SC Refuses To Entertain Plea For Scrapping TDS System Under Income Tax Law

Trust, Talent Attracting Investors To India: Vaishnaw

‘What Is Difference Between An Animal & A Man…’: SC Slams Man For Ill-Treating Wife, Daughters

Amul Cuts Milk Prices For One-litre Packs By Rs 1 Across India

NITI Aayog’s Fiscal Health Index: Odisha, Chhattisgarh Lead, Punjab And West Bengal Lag

Submission Of Age, Quota-Related Papers Made Mandatory For Civil Services Exam Application

Great Interest for India Among Global Food Majors: Chirag Paswan

India Demands Action Against Elements Disrupting Screening Of 'Emergency' In UK

EAM Jaishankar Meets Indonesian President Subianto

Featured

LIFESTYLE

National Girl Child Day Special Interview: How First Indian Woman Paralympic Deepa Malik Proved Ability Can Outshine Disability

8 Min Read

Jan 24, 2025

HEALTH

AI To Affordable Care, What India’s Healthcare Sector Is Hoping For In The Union Budget 2025

4 Min Read

Jan 15, 2025

BHARAT

Whatever Was Done In Galwan Shouldn’t Get Repeated: Army Chief

3 Min Read

Jan 15, 2025

ENTERTAINMENT

IMDb's 20 Most Anticipated Films of 2025: Salman's Sikandar or Yash Starrer Toxic, Which One Topped the List?

3 Min Read

Jan 15, 2025

Astrazeneca

Latest

Featured

National Girl Child Day Special Interview: How First Indian Woman Paralympic Deepa Malik Proved Ability Can Outshine Disability

AI To Affordable Care, What India’s Healthcare Sector Is Hoping For In The Union Budget 2025

Whatever Was Done In Galwan Shouldn’t Get Repeated: Army Chief

IMDb's 20 Most Anticipated Films of 2025: Salman's Sikandar or Yash Starrer Toxic, Which One Topped the List?

Quick Links / Policies

Get Us On

Featured

National Girl Child Day Special Interview: How First Indian Woman Paralympic Deepa Malik Proved Ability Can Outshine Disability

AI To Affordable Care, What India’s Healthcare Sector Is Hoping For In The Union Budget 2025

Whatever Was Done In Galwan Shouldn’t Get Repeated: Army Chief

IMDb's 20 Most Anticipated Films of 2025: Salman's Sikandar or Yash Starrer Toxic, Which One Topped the List?